|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 October 2015 |
|
Main ID: |
NCT02563418 |
|
Date of registration:
|
08/09/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
VOG-HD |
|
Scientific title:
|
Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study |
|
Date of first enrolment:
|
May 2014 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02563418 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Sophie Hue |
|
Address:
|
|
|
Telephone:
|
33 (0)241353800 |
|
Email:
|
sophie.hue@chu-angers.fr |
|
Affiliation:
|
|
|
|
Name:
|
D Milea |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
damilea@chu-angers.fr |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Corrected visual acuity >1/10
- Aged over 18 years
- Patient with the mutation that is to say the presence of an abnormal number of
trinuclide: CAG> 38 in the first exon of the huntingtin gene.
- Total Functional Capacity Scale (CFT) = 3
Exclusion Criteria:
- Patients or trustworthy person who have not given their written consent, informed and
signed.
- Patients are not affiliated or who are not entitled to Social Security
- Private patients of liberty by administrative or judicial decision, or patients
supervision
- Associated disease with neurological repercussions
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Huntington Disease
|
|
Intervention(s)
|
|
Device: Eye-tracking
|
|
Primary Outcome(s)
|
|
saccadic measures with the eye tracker
[Time Frame: 1 day]
|
|
Secondary ID(s)
|
|
AOI 2013 - 11
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|